🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Oscar Health, Inc. OSCR R2K

Healthcare · Healthcare Plans · United States
https://www.hioscar.com

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

READ MORE ›
$22.23
+61.09% 1Y

Market & Price

Market Cap
$6.70B
Current Price
$22.23
High / Low (52W)
$25.30 / $10.85
Beta
2.34

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
15.89
PEG Ratio
-
Book Value
$5.57
Price to Book
3.99
P/S
0.50
EV/EBITDA
9.57
Dividend Yield
-

Profitability & Returns

ROCE
-
ROE
-2.62%
ROA
0.09%
Profit Margin
-0.30%
Op Margin
15.15%
EPS (Latest Qtr)
$2.07
EPS (TTM)
$-0.54

Balance Sheet & Liquidity

Debt/Equity
0.29
Quick Ratio
1.07
Current Ratio
1.09
Debt
$482.24M
Total Assets
$6.33B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
5.39%
Chg in Prom Hold
-
FII / Inst Holding
67.41%
Chg in FII Hold
0.01%

Financial Snapshot

Enterprise Value
$380.76M
Total Revenue (TTM)
$13.30B
EBITDA
$39.78M
Free Cash Flow
$1.63B
Operating Cash Flow
$2.84B
Shares Outstanding
265.90M
Gross Margin
17.39%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
41.55%
Profit 5Y
8.97%
Revenue (YoY)
52.60%
Earnings (YoY)
125.60%

PROS

  • Compounding revenue at 41.6% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 OSCR Oscar Health, Inc. R2K 22.23 - $6.70B - - -2.62% 41.55% 8.97%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ---341.00K353.00K1.55M18.49M20.45M19.42M5.00M5.08M5.54M5.63M5.23M-3.05B2.86B2.99B2.81B4.65B
Cost of Revenue --------------------
Gross Profit --------------------
Operating Expenses --------------------
Operating Income -95.95M-39.35M-80.13M-64.04M-72.51M-211.68M-68.53M-106.49M-192.37M-25.36M-6.53M-58.24M185.56M67.81M-294.20M-227.69M-132.43M-353.78M704.16M
EBITDA --------------------
Interest Expense ---------------5.99M5.85M6.86M-1.10M5.38M
Pretax Income ---------------288.21M-233.54M-139.29M-352.68M698.77M
Tax Provision ---------------12.71M-5.04M-1.81M-247.00K19.75M
Net Income -96.88M-40.94M-79.13M-88.88M-73.32M-211.48M-75.15M-112.16M-192.91M-39.77M-15.53M-65.40M177.37M56.21M-275.27M-228.36M-137.45M-352.61M679.00M
Diluted EPS -3.36-1.42-2.72-1.00-0.35-1.02-0.36-0.53-0.91-0.18-0.07-0.290.620.20-0.92-0.89-0.53-1.242.07

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -0-4.13B5.86B9.18B11.70B
Cost of Revenue -------
Gross Profit -------
Operating Expenses -------
Operating Income -259.39M-402.27M--587.45M-242.70M57.16M-419.70M
EBITDA -------
Interest Expense ---22.62M24.60M23.73M17.60M
Pretax Income ----610.08M-267.30M33.43M-437.30M
Tax Provision ----523.00K3.29M7.30M5.61M
Net Income -261.18M-406.82M--606.27M-270.73M25.43M-443.15M
Diluted EPS -9.06-14.16--2.85-1.220.10-1.69

Compounded Sales Growth

5 Years:41.55%
1 Year:52.60%

Compounded Profit Growth

5 Years:8.97%
1 Year:125.60%

Stock Price Performance

1 Year:+61.09%
6 Months:+32.88%
3 Months:+62.98%
1 Month:+23.98%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -2.27B-4.53B3.60B4.84B6.33B
Current Assets -------
Cash & Equivalents 336.64M826.33M-1.56B1.87B1.53B2.77B
Inventory -------
Receivables ---1.11B442.46M607.43M542.39M
Total Liabilities -1.82B-3.63B2.80B3.82B5.34B
Current Liabilities -1.67B-----
Long Term Debt -142.49M-298.00M298.78M299.56M430.10M
Total Debt ---298.00M298.78M299.56M430.10M
Total Equity --1.30B-890.38M803.97M1.01B977.65M
Shares Outstanding ---216.61M229.70M250.80M298.00M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -165.37M222.73M-380.35M-272.16M978.19M1.09B
Investing Cash Flow 150.51M-344.71M--226.52M577.19M-1.39B-241.06M
Financing Cash Flow -2.12M611.71M-301.11M6.45M68.39M399.21M
Capital Expenditure ----29.01M-25.58M-27.90M-36.37M
Free Cash Flow ---351.34M-297.74M950.30M1.06B
Net Change in Cash ---454.94M311.47M-340.85M1.25B
Share Buybacks 2.99M00----

Ratios (Annual)

Figures in %.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------
Operating Margin % ----14.2%-4.1%0.6%-3.6%
Net Margin % ----14.7%-4.6%0.3%-3.8%
ROE % -31.4%--68.1%-33.7%2.5%-45.3%
ROCE % --66.3%-----

Shareholding Pattern

Insiders
5.39%
Institutions
67.41%
Public Float
71.25%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 6.51% 17.31M $384.79M
2 T. Rowe Price Investment Management, Inc. 4.38% 11.64M $258.86M
3 Vanguard Capital Management LLC 4.05% 10.78M $239.59M
4 Vanguard Portfolio Management LLC 3.97% 10.55M $234.43M
5 American Century Companies Inc 2.64% 7.03M $156.26M
6 Thrive Capital Management, LLC 2.39% 6.34M $141.02M
7 BIT Capital GmbH 2.38% 6.32M $140.53M
8 Shaw D.E. & Co., Inc. 2.06% 5.49M $121.94M
9 State Street Corporation 1.98% 5.26M $116.98M
10 Geode Capital Management, LLC 1.89% 5.03M $111.87M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for OSCR

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space